
Bead BioPharma emerges from stealth with novel drug platform
Bead BioPharma has emerged from stealth by submitting a patent for a novel cancer drug platform. The life sciences company, backed by Archangels, submitted the patent in efforts to launch its formal entry into one of the most competitive sectors of global oncology. Bead BioPharma is focused on antibody-drug conjugates (ADCs), a… Read More














